Comparing High Tone Power Therapy and TENS for Diabetic Nerve Pain

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of High Tone Power Therapy compared to Transcutaneous Electrical Nerve Stimulation (TENS) in alleviating polyneuropathic pain in diabetic patients. Sixty male patients aged 50-60 with diabetic polyneuropathy will be randomly assigned to receive either therapy three times a week for three months. The High Tone Power Therapy will utilize a frequency range of 4096 Hz to 31768 Hz, while TENS will use frequencies from 2 to 120 Hz. The goal is to identify a non-pharmacological treatment option that can improve patient symptoms and enhance their quality of life.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* The patient selection will be according to the following criteria:

  1. Sixty male patients are diagnosed with diabetic polyneuropathy their ages will be ranged from 50-60 years old.
  2. All patients are ambulant independently.
  3. All patients are under full medical control
  4. HbA1c is ranged from 6.5 : 7 %.
  5. Patients has diabetes more than 10 years.

Exclusion Criteria:

* The participants will be excluded if they meet one of the following criteria:

  1. Psychiatric disorders or seizures.
  2. Visual and auditory impairment or tremors influencing balance.
  3. Other neuromuscular disorders.
  4. Foot deformities and ulcers.
  5. Lower limb operations.
  6. Feverish systemic infection
  7. cardiac pacemaker.

Where it's running

• Om Elmasryeen Genral Hospital
  Giza, Egypt Recruiting

Study contacts

• Study coordinator: zeinab Awadallah, master
• Email: zeezee.awad88@hotmail.com
• Phone: +201285819342

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Differentiating heart disease in autoimmune vs. type 2 diabetes

  This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.

  Recruiting University of Roma La Sapienza · Rome, Roma · NCT07911007

• High BMI and periodontitis in Thai adults under 60

  This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.

  Recruiting Mahidol University · Bangkok, Ratchathewi · NCT07880717

• Reset-INSPIRE: See if CGM can reveal insulin sensitivity in people at risk for MASLD

  This study tests whether real-time CGM data can accurately reflect insulin sensitivity in adults without diabetes who are at risk for MASLD.

  Recruiting National University Health System, Singapore · Singapore, Singapore · NCT07861191

• Telemonitoring for Better Glycemic Control in Tunisian Adults with Diabetes

  This trial tests whether remote diabetes management through a mobile app and web platform can improve blood sugar control in adults with diabetes in Tunisia compared with standard care.

  Recruiting University of Monastir · Monastir · NCT07774078

• Rapid guideline-based therapy after a heart attack

  This project tests whether starting guideline-driven secondary prevention soon after a heart attack helps people who had PCI reach better risk-factor control and fewer heart events.

  Recruiting Zuyderland Medisch Centrum · Heerlen, Limburg · NCT07773272

• Impact of a Clinical Information System on hospital outcomes for adults with chronic diseases

  This study tests whether implementing a Clinical Information System helps reduce readmissions or death within 30 days after hospital discharge for adults with chronic conditions in Alberta.

  Recruiting University of Calgary · Calgary, Alberta · NCT07609381

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.